Literature DB >> 15976142

Oligofructose promotes satiety in rats fed a high-fat diet: involvement of glucagon-like Peptide-1.

Patrice D Cani1, Audrey M Neyrinck, Nicole Maton, Nathalie M Delzenne.   

Abstract

OBJECTIVE: To analyze the putative interest of oligofructose (OFS) in the modulation of food intake after high-fat diet in rats and to question the relevance of the expression and secretion of intestinal peptides in that context. RESEARCH METHODS AND PROCEDURES: Male Wistar rats were pretreated with standard diet or OFS-enriched (10%) standard diet for 35 days followed by 15 days of high-fat diet enriched or not with OFS (10%) treatment. Body weight, food intake, triglycerides, and plasma ghrelin levels were monitored during the treatment. On day 50, rats were food-deprived 8 hours and anesthetized for blood and intestinal tissue sampling for further proglucagon mRNA, glucagon-like peptide (GLP)-1, and GLP-2 quantification.
RESULTS: The addition of OFS in the diet protects against the promotion of energy intake, body weight gain, fat mass development, and serum triglyceride accumulation induced by a high-fat diet. OFS fermentation leads to an increase in proglucagon mRNA in the cecum and the colon and in GLP-1 and GLP-2 contents in the proximal colon, with consequences on the portal concentration of GLP-1 (increase). A lower ghrelin level is observed only when OFS is added to the standard diet of rats. DISCUSSION: In rats exposed to high-fat diet, OFS is, thus, able to modulate endogenous production of gut peptides involved in appetite and body weight regulation. Because several approaches are currently used to treat type 2 diabetes and obesity with limited effectiveness, dietary fibers such as OFS, which promote the endogenous production of gut peptides like GLP-1, could be proposed as interesting nutrients to consider in the management of fat intake and associated metabolic disorders.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15976142     DOI: 10.1038/oby.2005.117

Source DB:  PubMed          Journal:  Obes Res        ISSN: 1071-7323


  106 in total

Review 1.  Regulation of energy balance by a gut-brain axis and involvement of the gut microbiota.

Authors:  Paige V Bauer; Sophie C Hamr; Frank A Duca
Journal:  Cell Mol Life Sci       Date:  2015-11-05       Impact factor: 9.261

2.  Consumption of wheat bran modified by autoclaving reduces fat mass in hamsters.

Authors:  Scott V Harding; Harry D Sapirstein; Todd C Rideout; Christopher P F Marinangeli; Arshala K M Dona; Peter J H Jones
Journal:  Eur J Nutr       Date:  2013-10-08       Impact factor: 5.614

3.  The role of the gut microbiota in nonalcoholic fatty liver disease.

Authors:  Ahmed Abu-Shanab; Eamonn M M Quigley
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-11-02       Impact factor: 46.802

Review 4.  Intestinal microbiota and type 2 diabetes: from mechanism insights to therapeutic perspective.

Authors:  Jun-Ling Han; Hui-Ling Lin
Journal:  World J Gastroenterol       Date:  2014-12-21       Impact factor: 5.742

Review 5.  Connection between gut microbiome and the development of obesity.

Authors:  Cuiting Zhi; Jingqing Huang; Jin Wang; Hua Cao; Yan Bai; Jiao Guo; Zhengquan Su
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-07-31       Impact factor: 3.267

Review 6.  Gut Microbiota in Obesity and Undernutrition.

Authors:  Nicolien C de Clercq; Albert K Groen; Johannes A Romijn; Max Nieuwdorp
Journal:  Adv Nutr       Date:  2016-11-15       Impact factor: 8.701

Review 7.  Gut microbiota and chronic kidney disease: evidences and mechanisms that mediate a new communication in the gastrointestinal-renal axis.

Authors:  Natalia Lucía Rukavina Mikusic; Nicolás Martín Kouyoumdzian; Marcelo Roberto Choi
Journal:  Pflugers Arch       Date:  2020-02-17       Impact factor: 3.657

8.  Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia.

Authors:  P D Cani; A M Neyrinck; F Fava; C Knauf; R G Burcelin; K M Tuohy; G R Gibson; N M Delzenne
Journal:  Diabetologia       Date:  2007-09-06       Impact factor: 10.122

Review 9.  Antihypertensive properties of plant-based prebiotics.

Authors:  Siok-Koon Yeo; Lay-Gaik Ooi; Ting-Jin Lim; Min-Tze Liong
Journal:  Int J Mol Sci       Date:  2009-08-10       Impact factor: 6.208

10.  Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability.

Authors:  P D Cani; S Possemiers; T Van de Wiele; Y Guiot; A Everard; O Rottier; L Geurts; D Naslain; A Neyrinck; D M Lambert; G G Muccioli; N M Delzenne
Journal:  Gut       Date:  2009-02-24       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.